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Abstract
Visceral leishmaniasis (VL) is characterized by loss of T-cell responsiveness and absence
of Leishmania-specific IFN-γ production by peripheral blood mononuclear cells. However,
the expressions of IFN-γ and TNF-α are up-regulated in the tissues and plasma of VL
patients. There is a paucity of information regarding the cytokine profile expressed by differ-
ent target tissues in the same individual and the changes it undergoes throughout the
course of infection. In this work we evaluated IFN-γ, TNF-α, IL-10, and TGF-βmRNA
expression using real-time RT-PCR in 5 target tissues at 6 months and 16 months post-
infection (PI) in a canine experimental model which mimics many aspects of human VL. The
spleen and liver of Leishmania infantum experimentally-infected dogs elicited a pro- and
anti- inflammatory response and high parasite density at 6 and 16 months PI. The popliteal
lymph node, however, showed an up-regulation of IFN-γ cytokin at commencement of the
study and was at the chronic phase when the IL-10 and TGF-β expression appeared. In
spite of skin parasite invasion, local cytokine response was absent at 6 months PI. Parasite
growth and onset of clinical disease both correlated with dermal up-regulation of all the stud-
ied cytokines. Our VL model suggests that central target organs, such as the spleen and
liver, present a mixed cytokine immune response early on infection. In contrast, an anti-
inflammatory/regulatory immune response in peripheral tissues is activated in the later
chronic-patent stages of the disease.
Introduction
In recent years, leishmaniasis has spread into formerly Leishmania-free ecoregions, becoming
the third most frequent opportunistic parasitic disease in HIV patients [1,2]. Visceral leish-
maniasis (VL) is caused by L. donovani and L. infantum and has a fatal outcome when let
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untreated. It is characterized by fever, hepatosplenomegaly, and cachexia which are thought to
be associated with the absence of a specific cellular immune reponse (CMI) during active dis-
ease [3–5]. Proinflammatory cytokines (IFN-γ and TNF-α), however, increase in tissues such
as the spleen, bone marrow (BM), lymph node (LN), and plasma [6–8] suggesting that instead
of a suppressed T helper (Th)1 response, active VL might be due to unresponsiveness to Th1
stimuli. In this regard, IL-10 and TGF-β, cytokines known to suppress CMI, are increased in
lesional tissues from human VL patients [7,9]. Knowledge concerning the cytokine VL profile
in human target organs is still limited as it requires potentially dangerous and time-consuming
invasive techniques.
Canine leishmaniasis (CanL) shares many characteristics of human VL, and the dog is the
main peridomestic reservoir of L. infantum [10]. Protective responses in dogs have been associ-
ated with low anti-Leishmania antibody levels and the activation of specific CMI, including the
production of Th1 cytokines, such as IFN-γ, TNF-α, and IL-2 [11,12]. On the other hand,
active disease is characterized by a marked humoral response, specific immunossupression,
and mixed Th1/Th2 cytokine profile [13–15]. Most research has, however, focused on the anal-
ysis of the immune response in peripheral blood even though it is currently accepted that the
immune response to the parasite is not identical in the whole host system but rather organ-spe-
cific [reviewed by [16]]. This mixed Th1/Th2 cytokine profile is as yet not well defined because
a number of studies evaluating different tissues obtained discrepant results [17–19]. In addi-
tion, whereas in human VL the role of IL-10 during active disease has been clearly established,
in CanL its action is still controversial. Some authors have associated IL-10 with an increase in
clinical signs [19,20] whilst others were unable to detect IL-10 accumulation during patent-
phase disease [14,17]. Few studies have analyzed the immunological response in more than
one target organ during CanL, and none at different times and compartments during disease
manifestation.
The aim of the current study was to analyze the cytokine expression in immunological
organs where antigen exposure and immune response take place, and also in organs targeted
by the pathogen for active multiplication and expansion. Since cytokine levels were monitored
at two different time points, we were able to gain unprecedented insight into how immunologi-
cal reactions against Leishmania are coordinated. Moreover, we explored potential links
amongst the spread of Leishmania, its progression, and the immune profile.
Material and Methods
Ethical statement
All procedures were approved by the Ethical Review Committee of Zoetis Manufacturing
Research Spain S L [formerly known as Fort Dodge Veterinaria S.A.] (L'Hostalnou de Bianya,
Girona, Spain) in compliance with national (Real Decreto 1201/2005) and European Union
regulations (European Directive 86/609/CE) for projects using animals for research purposes.
The project license number assigned by the Ethics Committee was number 132 and the permit
number allocated by the Spanish Authorities was number 3303.
Dogs and samples
Thirty-six, six-month-old, intact, female beagles weighing approximately 10 kg from Zoetis
Manufacturing Research Spain S L [formerly known as Fort Dodge Veterinaria S.A.] (L'Hostal-
nou de Bianya, Girona, Spain) received routine vaccinations and were dewormed. They were
housed in pens of six (~13 m² pen) or seven animals (~15 m² pen) under conditions designed
to exclude natural Leishmania infection. They had direct contact with pen mates and neighbor-
ing pens, and received daily exercise in the facility corridors. There was environmental
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enrichment in the form of several toys and the interior of each cage had an elevated platform
onto which the dogs could jump or hide below. None of the 36 dogs had detectable levels of
anti-Leishmania antibodies in serum, or Leishmania DNA in BM and blood samples.
L. infantum (strain MCAN/ES/92/BCN-83/MON-1), obtained from a non-treated naturally
infected dog, was passaged through hamsters in order to retain its full virulence. The spleens
from infected hamsters were homogenized in Schneider’s Drosophilamedium (Sigma, St Louis,
MO, USA) supplemented with 20% v/v fetal calf serum (Gibco, Paisley, Scotland) and
25 μgmL−1 gentamicin (Sigma), and centrifuged at 500 g for 10 min at 4°C. The resulting
supernatant was washed three times and resuspended in 0.9% NaCl at a concentration of
2 × 108 amastigotesmL−1. Thirty-one dogs were immediately infected by intravenous injection
of 1 mL of the resuspended parasites. The remaining 5 non-infected dogs were used as controls
(NID). To minimize suffering, clinical end points for withdrawal were established based on
clinical signs including severe skin lesions, marked lameness, debilitating diarrhea, neurological
signs or critical bleeding from any orifice.
There were no deaths during the study period in any of the groups. Twenty-four infected
dogs were euthanized at 6 months post-infection (PI) (Group 6-m) and 7 infected dogs at 16
months PI (Group-16m). The 5 NID dogs were euthanized at the end of the study. Prior to
euthanasia, a complete physical examination was carried out and blood collected for clinical
biochemistry analysis (renal and hepatic function tests, and protein electrophoresis). Clinico-
pathological findings compatible with CanL were rated as previously described [21] and
merged to obtain an overall clinico-pathological score (CPS) (Table 1). Euthanasia was carried
out using a distress-free and painless protocol. First the dogs were anaesthetized with bupre-
norphine (Buprex1, Schering Plough) 10 μg/kg plus either medetomidine hydrochloride
(Domtor1, Orion) 10 μgkg−1 or acepromacine maleate (Calmo Neosan1, Pfizer) 0.5 mgkg−1
administered intramuscularly. Approximately 30 minutes later they were euthanized with an
intravenousoverdose (>200 mgkg−1) of pentobarbital sodium (Dolethal1, Vetoquinol). Sam-
ples from the spleen, BM from the costochondral juntion, liver, popliteal LN, and healthy
pinna skin were collected, snap-frozen in liquid nitrogen, and stored at −80°C until use.
Table 1. Clinicopathological findings in experimentally infected dogs at 6 months and 16 months post-infection.
Clinicopathological Findings 6 Month Group 16 Month Group
Number of Dogs (%) Median Score Number of Dogs (%) Median Score
Weight loss 0 0 7 (100%) 1
Pale mucosa 0 0 5 (71%) 1
Lymphadenopathy 14 (58%) 1 7 (100%) 3
Ocular lesions 0 0 4 (57%) 1
Desquamation 0 0 6 (86%) 2
Alopecia 6 (25%) 0 7 (100%) 2
Skin ulcers 0 0 1 (14%) 0
Dermatitis 1 (4%) 0 4 (57%) 2
Nodular skin lesions 1 (4%) 0 1 (14%) 0
Mucocutaneous signs 0 0 1 (14%) 0
Gastrointestinal signs 0 0 1 (14%) 0
Lameness 0 0 1 (14%) 0
Clinical Score > 0 14 (58%) 1 7 (100%) 12
Clinical biochemistry 19 (79%) 1,2 7 (100%) 8,6
Clinicopathological score 2.9 22.5
doi:10.1371/journal.pone.0155224.t001
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Serological tests
The dynamics of IgG and IgA against crude total L. infantum antigen (CTLA) in serum has
been previously described [22]. Results were expressed as ELISA units (EU) in reference to a
known positive serum used as a calibrator and arbitrarily set at 1 EU. Cut-off (mean + 3 SD for
32 dogs from non-endemic areas) was at 0.250 EU for IgG and 0.600 EU for IgA. Levels were
categorized [23].
Real-time PCR amplification of L. infantum DNA in tissue samples
DNA was extracted using High Pure PCR Template Kit (Roche). L. infantum DNA was specifi-
cally detected and quantified by Taqman qPCR (Applied Biosystems, Foster City, California,
USA) as previously described [24] with minor modifications. Targeted qPCR conserved DNA
regions of the kinetoplast minicircle DNA from L. infantum (LEISH-1 5’-AACTTTTCTGGTC
CTCCGGGTAG-3’; LEISH-2 5’-ACCCCCAGTTTCCCGCC-3’ and TaqMan-MGB probe
FAM-5’-AAAAATGGGTGCAGAAAT-3’- MGB). A standard curve was generated from Leish-
mania DNA extracted from 1 × 107 parasites, using serial dilutions from 103 to 10−3 parasites.
Thermal cycling profile was 50°C for 2 min, 95°C for 10 min, 40 cycles at 95°C for 15 s, and
60°C for 1 min. Analyses were performed in a Step One Plus Real Time PCR System (Applied
Biosystems Laboratories, Foster City, CA, USA). Each standard, sample, and a negative control
was analyzed in triplicate for each run. The number of parasites per milligram of tissue was cal-
culated and categorized [25]. This protocol was able to detect 0.001 parasites per reaction tube
with a dynamic range of 107. The median slope of three different standard curves was −3.44,
and the qPCR efficiency of 98%. Quantification was linear between 103 and 10−2 parasites per
reaction tube (correlation = 0.99).
Quantitative reverse transcription PCR (RT-qPCR) analysis of canine
cytokines
Cytokine production was analyzed in tissues collected from the 5 NID dogs, 12 dogs from the
6-m group, and 7 from the 16-m group by RT-qPCR. Total RNA was extracted using Ribo-
Pure™ (Ambion). RNA samples were DNase treated with TURBO-DNA free Kit (Ambion) and
quantified using NanoDrop-1000 UV-V Spectrophotometer, accepting ratios A260/A280 1.7–
2.1. Each sample was stored at −80°C until use.
qPCR analyses for cytokine expression were performed with an Applied Biosystems ABI
Prism 7000 DNA sequence detection system (PE Applied Biosystems, Foster City, CA, USA).
Reverse transcription and qPCR amplifications were carried out in a single well with TaqMan
PCR Core Reagent Kit (PE Applied Biosystems). The amplification conditions, gene-specific
primers and probes were as previously described [26]. Parallel reactions were performed for
canine IFN-γ, IL-10, TGF-β, and TNF-α transcripts from the tissues. Three replicate analyses
were performed and the amount of target RNA was normalized with respect to the control
(housekeeping) gene β-actin (ΔC). Results were expressed according to the 2−ΔΔCt method
using the mean value of the ΔC of the NID-group as calibrator.
Statistics
Nonparametric statistical analysis was performed with the SPSS version 15.0 (SPSS, Inc., Chi-
cago, IL). Differences between groups were analyzed by the Mann-Whitney U test, and correla-
tions by Spearman's rank correlation coefficient. A p-value< 0.05 was employed.
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Results
Clinical, serological, and parasitological course
At 6 months PI the 24 evaluated dogs scored a CPS of 2.9 [1–5] (median [interquartil range])
with lymphadenopathy as the most frequent clinical sign (Table 1). Leishmania-specific
IgG-CTLA seroreactivity was detected in all animals (145.08 EU [84.6–219.3]) but one. In
contrast, only 9 of them presented Leishmania-specific IgA-CTLA seroreactivity (79.2 EU
[51.7–138.2]). Parasites were detected in all the evaluated tissues for all the dogs from this
group (Fig 1).
At 16 months PI all dogs showed symptoms and clinical chemistry compatible with leish-
maniosis (Table 1), reaching a CPS of 22.5 [18–24], significantly different to that computed in
dogs evaluated at 6 months (Mann-Whitney U test; P< 0.001). Leishmania-specific IgG-CTLA
(300 EU [296.04–311.75]) and Leishmania-specific IgA-CTLA (119.4 EU [85.7–145.1]) seror-
eactivities were higher than those detected in dogs at 6 months PI, but only the increase in spe-
cific IgG levels was statistically significant (Mann-Whitney U test; P< 0.001). The parasite
load increased in the skin between the two time points of the experimental infection (Mann-
Whitney U test; P = 0.038). We also detected an increase in the LN and a decrease in the liver
although these differences were not statistically significant. In contrast, the at 16 months PI the
parasite load decreased in the spleen with respect to 6 months PI (Mann-Whitney U test;
P = 0.010) (Fig 1).
Course of cytokine levels in target organs
mRNA levels for IFN-γ, TNF-α, IL-10, and TGF-β in the spleen, liver, BM, LN, and skin are
shown in Figs 2 and 3.
At 6 months PI there was a statistically significant increase in the spleen (Mann-Whitney U
test; P = 0.027), liver (Mann-Whitney U test; P = 0.040), BM (Mann-Whitney U test;
P = 0.003), and LN (Mann-Whitney U test; P = 0.027) for IFN-γ when compared to the NID
group. As for the other analyzed pro-inflamatory cytokine, TNF-α, only BM showed a statisti-
cally significant increase (Mann-Whitney U test; P = 0.003) when compared to the NID group.
With regard to anti-inflammatory/regulatory cytokines, there was a statistically significant
increase in the spleen (Mann-Whitney U test; P = 0.037) for TGF-β and in the liver (Mann-
Whitney U test; P = 0.040) for IL-10 when compared to the NID group. It is worth highlighting
Fig 1. L. infantum parasite load detected at 6 months and 16months post-infection in spleen, BM, liver, popliteal LN, and healthy pinna skin by
real-time PCR. The number of parasites per milligram of tissue was calculated using a standard curve generated from DNA extracted from a known
number of L. infantum promastigotes.
doi:10.1371/journal.pone.0155224.g001
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Fig 2. Median cytokine expression in (A) spleen, (B) liver, and (C) bone marrow (BM) samples
throughout the course of L.infantum experimental infection. Y-axis: cytokine; X-axis: fold-increase of
cytokine expression according to the 2−ΔΔCt method using the mean value of the ΔC of the Non-infected
dogs (NID) group as calibrator. White bars: NID; Bright-grey bars: dogs after 6 months (6-m) of L. infantum
experimental infection; Dark-grey bars: dogs after 16 months (16-m) of L. infantum experimental infection.
Significant differences in median cytokine levels among groups are indicated by * P < 0.05, ** P < 0.01,
*** P < 0.001.
doi:10.1371/journal.pone.0155224.g002
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that despite the presence of parasites in the skin no cytokine expression was detected at 6
months PI.
At 16 months PI, when all the infected dogs presented patent leishmaniosis, the statistically
significant increase in IFN-γ was maintained in the liver (Mann-Whitney U test; P = 0.006),
BM (Mann-Whitney U test; P = 0.043), and LN (Mann-Whitney U test; P = 0.003) when com-
pared to the NID group. This was also the case for TGF-β in the spleen (Mann-Whitney U test;
P = 0.010) and for IL-10 in the liver (Mann-Whitney U test; P = 0.010).
In LN there was a statistically significant increase in TGF-β (Mann-Whitney U test;
P = 0.018) and IL-10 (Mann-Whitney U test; P = 0.003) when compared to NID; whereas pre-
viously, at 6 months, there had been only mRNA expression for IFN-γ. Finally, and in contrast
to what occurred at 6 months PI, in the skin there was a marked expression of all the analyzed
cytokines when compared to the NID group: IFN-γ (Mann-Whitney U test; P = 0.003), TNF-α
(Mann-Whitney U test; P = 0.018), IL-10 (Mann-Whitney U test; P = 0.010), and TGF-β
(Mann-Whitney U test; P = 0.003).
Fig 3. Median cytokine expression in (A) popliteal lymph node and (B) healthy pinna skin samples
throughout the course of L.infantum experimental infection. Y-axis: cytokine; x-axis: fold-increase of
cytokine expression according to the 2−ΔΔCt method using the mean value of the ΔC of the Non-infected
dogs (NID) group as calibrator. White bars: NID; Bright-grey bars: dogs after 6 months (6-m) of L. infantum
experimental infection; Dark-grey bars: dogs after 16 months (16-m) of L. infantum experimental infection.
Significant differences in median cytokine levels among groups are indicated by * P < 0.05, ** P < 0.01,
*** P < 0.001.
doi:10.1371/journal.pone.0155224.g003
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Relationships between tissue cytokine expression and markers of
Leishmania infection
The relationships between tissue cytokine expression and markers of Leishmania infection are
summarized in Table 2.
A positive correlation was found in the spleen between parasite load and both IFN-γ and
TGF-β expression. TGF-β was the only cytokine whose expression correlated with CPS. It
should be noted that no correlation was found between cytokines and Leishmania-specific IgG
or IgA antibody levels in this tissue.
When we evaluated the relationship between different parameters in liver samples, we
found that IFN-γ correlated with both parasite load and Leishmania-specific IgG and IgA anti-
body levels. IL-10, however, was the only cytokine whose expression correlated with CPS in
this organ.
BM showed that expression of IFN-γ and TNF-α correlated with parasite load and Leish-
mania-specific IgA.
IFN-γ, IL-10, and TGF-β were positively correlated with CPS and Leishmania-specific IgG
levels in LN. Interestingly, popliteal LN was the only tissue where no cytokine correlated with
the parasite load.
Table 2. Relationships amongst cytokine expression in different target organs and clinicopathological score, Leishmania-specific IgG and IgA lev-








ρa P ρ P ρ P ρ P
SPLEEN IFN-γ 0.197 NSb 0.122 NS 0.271 NS 0.542 0.008
IL-10 0.177 NS 0.041 NS -0.073 NS 0.397 NS
TGF-β 0.459 0.024 0.343 NS 0.353 NS 0.557 0.006
TNF-α -0.315 NS -0.258 NS -0.26 NS 0.153 NS
LIVER IFN-γ 0.392 NS 0.528 0.014 0.655 0.001 0.47 0.027
IL-10 0.450 0.036 0.446 0.043 0.345 NS 0.373 NS
TGF-β -0.228 NS 0.03 NS 0.035 NS 0.045 NS
TNF-α -0.188 NS -0.033 NS 0.1 NS 0.02 NS
BMc IFN-γ 0.396 NS 0.309 NS 0.582 0.018 0.632 0.011
IL-10 -0.201 NS -0.246 NS -0.208 NS -0.348 NS
TGF-β 0.138 NS -0.05 NS 0.25 NS 0.407 NS
TNF-α 0.455 NS 0.314 NS 0.584 0.017 0.624 0.013
LNd IFN-γ 0.626 0.001 0.746 <0.001 0.537 0.008 0.302 NS
IL-10 0.561 0.004 0.584 0.003 0.447 0.033 0.238 NS
TGF-β 0.514 0.01 0.432 0.039 0.381 NS 0.364 NS
TNF-α 0.236 NS 0.312 NS 0.415 0.049 0.12 NS
SKIN IFN-γ 0.817 <0.001 0.810 <0.001 0.644 0.001 0.596 0.003
IL-10 0.656 0.001 0.656 0.001 0.492 0.02 0.558 0.006
TGF-β 0.584 0.003 0.599 0.003 0.439 0.041 0.386 NS
TNF-α 0.711 <0.001 0.655 0.001 0.490 0.021 0.684 <0.001
a Spearman coefficient of correlation
b non significant (P > 0.05)
c Bone Marrow
d Popliteal Lymph Node
doi:10.1371/journal.pone.0155224.t002
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There was a positive correlation in the skin among all cytokines and all markers of Leish-
mania infection, with the exception of TNF-α levels and dermal parasite density.
All the results obtained in the present study are summarized in Fig 4.
Discussion
L. infantum is an obligatory, intracellular parasite with tropism towards macrophages in spe-
cific organs such as the spleen, liver, BM, LN, and skin. To date, most immunological studies
have either focused on the analysis of the immune response in peripheral blood or have only
examined one tissue or time point during Leishmania infection. The present study evaluated
the immune response and parasite load of different organs in 6-month experimentally-infected
dogs that were still clinically healthy, and in 16-month experimentally-infected dogs suffering
from the patent phase of the disease. Our aim was to establish relationships amongst the spread
of Leishmania, its progression, and the immune profile.
It is clear from our data that L. infantum experimental infection in dogs leads to an
increased expression of IFN-γ in most target organs which is maintained in later stages of the
disease. Other studies, in both experimentally and naturally infected dogs, have already
reported an augmentation for some tissues such as the spleen [27], liver [28], BM [17], and LN
[29] during the patent phase of the disease. Until recently, however, there has been no evidence
that this pro-inflammatory response is widespread and positively correlated with the parasite
load for each organ or tissue. Our results are in accordance with previous studies carried out in
hamsters and humans suffering from VL where high parasite loads were observed even in pro-
inflammatory environments [6,30,31]. IFN-γ production during the patent phase rules out a
Th1 inherent defect although its expression is not enough to confer full protection, as has
already been observed in human VL [32]. In our study, it is probable that most of the dogs
expressed IFN-γ in response to the presence of parasites in the target organs, and this inflam-
matory response persisted due to an overreaction against persistent infection [33]. Our findings
raise the question of whether the expression of IFN-γ in the 16-month group exacerbated the
clinical signs and was actually involved in CanL immunopathology. A similar phenomenon
Fig 4. Graphical representation of cytokine activation, parasite load, and Leishmania-specific
antibody levels at 6 and 16months PI. Cytokines: Green = activation of pro-inflammatory cytokines
(statistically different from NID). Red = activation of anti-inflammatory/regulatory cytokines (statistically
different from NID). Parasite load was categorized as low (L: 1–100 parasites mg-1 of tissue), medium (M:
101–1000), high (H: 1001–10,000), and very high (VH > 10,000). Antibody levels (Leishmania-specific IgG
and IgA) were categorized as low (L: 1 × cut-off), medium (M: 2 × cut-off), and high (H: 3 × cut-off).
doi:10.1371/journal.pone.0155224.g004
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has been observed in human mucocutaneous leishmaniasis [34] and other parasitic diseases
such as malaria [35] and Chagas disease [36]. A number of authors have provided contradic-
tory results after analyzing peripheral blood mononuclear cells from infected dogs which did
not produce IFN-γ [11]. Nevertheless, our work demonstrates that in experimental CanL the
immune system is greatly stimulated in target organs such as the spleen and liver, and it is pos-
sible that other factors may counteract its leishmanicidal action.
IL-10 and TGF-β are macrophage deactivating cytokines which play key roles in murine
and human VL [37,38]. In the present study, we found that experimental infection with L.
infantum led to significantly increased IL-10 and TGF-β expression in the liver and spleen,
respectively. These two cytokines are produced by various cell types, including macrophages, B
lymphocytes, and CD4+ T cells, and exert their immunosuppressive action by suppressing
macrophage activation, dendritic cell migration, and protective Th1 responses [33]. Co-expres-
sion of pro- and anti-inflammatory cytokines in the spleen and liver, a mixed Th1/Th2 pattern,
has been previously described. This relationship suggests that an equilibrium between the two
types of responses is required in order to control the disease [27,39]. In the present study, we
did not observe significant differences in the expression of any of the evaluated cytokines in the
spleen or liver when comparing clinically healthy, infected dogs with sick ones. A finding that
was probably due to the high parasite load present in these organs in both groups of dogs and
which implies a very strong immune activation. As a consequence, our results suggest that, in
this model, measuring the expression of cytokines in the spleen or liver serves no purpose from
a prognostic point of view.
To the best of our knowledge, there are only two reports on the expression of cytokines in
the BM of dogs suffering from leishmaniasis [17,29]. In agreement with our results, they con-
clude that BM tends to develop high parasite loads in a predominantly pro-inflammatory envi-
ronment, characterized by an increased expression of IFN-γ and TNF-α, and no detection of
IL-10. The augmentation of TNF-α in BM, the highest detected in our study, may have been
due to the stimulation of myelopoiesis as previously described in L. infantum infected dogs
[40] and L. donovani infected mice [41]. BM tissue could provide progenitor cells to the spleen
that activate and contribute to granuloma formation [42,43].
A major finding of our study is the different pattern of cytokine expression observed when
comparing skin and LN with the other analyzed tissues. At 6 months PI no significant increase
in cytokine expression in skin was found and only an up regulation of IFN-γ was detected in
LN. These results show for the first time that there is a silent phase in the skin: parasite invasion
takes place without cytokine expression, similar to that which occurs in L.major infected mice
[44]. This silent phase may allow Leishmania to survive and settle in the dermis without the
presence of a local immune response that would lead to parasite elimination. Such a lack of
immune response could play a major role in the transmission cycle of the parasite and might
explain why clinically healthy, naturally-infected dogs are infective to phlebotomines [45]. Our
results indicate that the phase of disease control during experimental infection was character-
ized by a pro-inflammatory immune response in peripheral LN in conjunction with a silent
phase in the skin.
In contrast, there was a sharp increase of expression of anti-inflammatory/regulatory
TGF-β and IL-10 cytokines at 16 months PI in LN and skin which paralleled the increased
parasite load in these tissues. Furthermore, there was also a major inflammatory response in
the skin. The skin and LN were the only tissues where the expression of all the cytokines cor-
related positively with the clinical score and with Leishmania-specific IgG and IgA (with the
exception of TNF-α in LN). Our results not only confirm the association of IL-10 and TGF-β
expressed in skin and LN with clinical signs [16,18,46], but also, for the first time, they can be
compared with the immune response in other target organs. The fact that the expression of
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anti-inflammatory/regulatory cytokines takes place only in the skin and popliteal LN of
16-month infected dogs is possibly due to the organs’ peripheral nature. Following an intrave-
nous administration of the parasite they are invaded later than the liver, spleen, and BM [47].
If the parasites can not be contained by the central target organs they then spread towards the
popliteal LN and skin where they increase their load and activate local immune pro- and anti-
inflammatory responses. The high level of skin IL-10 expression found at 16 months PI, the
greatest out of all the analyzed tissues, is noteworthy. At this point it is difficult not to draw a
parallel between that which takes place in Leishmania- sick dogs and human post-kala-azar
dermal leishmaniasis (PKDL). Differences aside, in the two instances there are skin lesions
produced by a Leishmania spp. with visceral tropism and high local IL-10 expression, and
both the affected humans and dogs play a paramount role in the transmission of the parasite
[48]. It would be of interest to compare the healthy and lesional skin of both dogs and humans
suffering from PKDL.
In short, our study shows that IFN-γ expression is present in most tissues at both 6 and 16
months PI. Nevertheless, the anti-inflammatory/regulatory immune response at 6 months PI
typically only occurs in the spleen and liver which is when the dogs are still clinically healthy
but carry high parasite loads in these organs. At 16 months PI, the immune response, charac-
terized by the expression of IL-10 and TGF-β, is highly activated in popliteal LN and skin, par-
alleling both the increase in parasite load and the appearance of clinical signs. From our
findings we postulate that sequential parasite dissemination, in tandem with a sequential deac-
tivating immune response, occurs in target organs in this CanL experimental model. Our study
contributes to characterizing this animal model in VL for vaccine research and should help to
identify new targets and strategies to fight this neglected tropical disease.
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